182 related articles for article (PubMed ID: 7645970)
21. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
22. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
23. Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents.
Gadjeva V
Eur J Med Chem; 2002 Apr; 37(4):295-300. PubMed ID: 11960664
[TBL] [Abstract][Full Text] [Related]
24. Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.
Fojo T; Farrell N; Ortuzar W; Tanimura H; Weinstein J; Myers TG
Crit Rev Oncol Hematol; 2005 Jan; 53(1):25-34. PubMed ID: 15607933
[TBL] [Abstract][Full Text] [Related]
25. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
26. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Brajtburg J; Elberg S; Schechtman KB; Medoff G
Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-HIV activity of new urea and nitrosourea derivatives of diamino acids.
Dulude H; Salvador R; Gallant G
Bioorg Med Chem; 1995 Feb; 3(2):151-60. PubMed ID: 7796048
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
29. Development of more selective anti-cancer nitrosoureas.
Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
[TBL] [Abstract][Full Text] [Related]
30. Chemical stability, alkylating activity, and lipophilicity of 1,1'-ethylene-bis(1-nitrosourea) and related compounds.
Morimoto K; Yamaha T; Nakadate M; Suzuki I
Gan; 1978 Feb; 69(1):139-42. PubMed ID: 640322
[TBL] [Abstract][Full Text] [Related]
31. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
32. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
[TBL] [Abstract][Full Text] [Related]
33. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
35. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds.
Kuo SC; Ibuka T; Huang LJ; Lien JC; Yean SR; Huang SC; Lednicer D; Morris-Natschke S; Lee KH
J Med Chem; 1996 Mar; 39(7):1447-51. PubMed ID: 8691475
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic effects of 13 nitrosoureas on the LSA lymphoma ascites tumor of the C57BL mouse.
Feola JM; Maruyama Y
Oncology; 1986; 43(6):378-84. PubMed ID: 3808571
[TBL] [Abstract][Full Text] [Related]
39. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
40. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
Fujimoto S; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]